Equillium Inc (EQ NASDAQ) stock market data APIs
$1.894
0.02(1.1%)
as of September 17, 2026
Try our APIs with
free plan!
Equillium Inc Financial Data Overview
Price chart is built with
Anychart
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Prev. Close
1.894
Open
1.9142
High
1.9557
Low
1.8173
52 wk Range
0.7562-3.54
Market Cap
118 M
Shares Outstanding
63 408 K
Revenue
4 392 K
EPS
-0.04
Beta
1.804
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Equillium Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Equillium Inc data using free add-ons & libraries
Get Equillium Inc Fundamental Data
Equillium Inc Fundamental data includes:
- Net Revenue: 4 392 K
- EBITDA: -19 200 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: -0.05
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Equillium Inc News
New
Equillium to Participate in Upcoming Investor Conferences
Equillium, Inc. LA JOLLA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory dis...
Which companies reporting earnings this week show the strongest bullish signals?
Quant rankings for the upcoming earnings calendar show strength concentrated across Industrials and Energy, while weakness is more pronounced in financials and materials. A total of 160 companies are ...
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504
Equillium, Inc. (NASDAQ:EQ), with a year-to-date gain of 89.68% and upside potential of 121.10%, secures a spot on our list of hot biotech stocks under $5 to buy.Analysts Grow More Convicted In Equill...
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
The targeted oncology sector is shifting after GSK (GSK [https://seekingalpha.com/symbol/GSK]) decided to buy [https://seekingalpha.com/news/4601644-gsk-to-buy-nuvalent-for-106b] Nuvalent (NUVL [https...
Get Equillium Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
